Contact this trialFirst, we need to learn more about you.
Small Molecule Inhibitor
CPI-0209 for Cancer and Lymphoma
Recruiting1 awardPhase 1 & 2
Grand Rapids, Michigan
This trial is testing a new drug, CPI-0209, to see if it's safe and effective in treating patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor of EZH2.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service